Link Pharma Chem Reports Q2 FY27 Net Loss Amid Revenue Decline
Link Pharma Chem Ltd 路 Financial Result 路 03 Nov 2026, 6:27 pm
Link Pharma Chem Reports Q2 FY27 Net Loss Amid Revenue Decline Link Pharma Chem posted a net loss of Rs 22.31 lakhs for the quarter ended 30th Sep'26, down from a net profit of Rs 1.56 lakhs in 30th Sep'25 and Rs 31.83 lakhs in 30th Jun'26. Revenue from operations fell 15.28% YoY to Rs 533.13 lakhs compared to Rs 629.32 lakhs in the corresponding prior-year quarter. For H1 ended 30th Sep'26, net profit declined 77.21% YoY to Rs 9.52 lakhs on flattish revenue of Rs 1,409.97 lakhs. Basic EPS stood at negative Rs 0.50 for the quarter.
Original exchange filing (PDF)
More announcements from Link Pharma Chem Ltd
- We herewith submit Non Applicability of Regulation 23(9) of SEBI (LODR) Regulations, 2015 on Disclosure of related party transactions for the Half year ended on 30th September, 2026. 路 03 Nov 2026
- Board meeting outcome of Board Meeting held on 3rd November, 2026 路 03 Nov 2026
- Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results .... 路 03 Nov 2026
- Disclosure order Regulation 30 read with Part A of Schedule III of SEBI Regulation 2015 order received from GST Appellate authority, Tribunal , Vadodara FY 2021-22. 路 13 Oct 2026
- Re-appointment of Mr. Satish G. Thakur as Whole Time Director for 3 years. 路 21 Aug 2026
- Re-appointment of Mr. Rishikesh Thakur as Managing Director of the Company for 3 years. 路 21 Aug 2026
- Voting Results pursuant to clause 44(3) of SEBI LODR Regulation,2015 and Scrutinizer''s report for 41st Annual General Meeting of the Company. 路 21 Aug 2026
- Voting Results pursuant to clause 44(3) of SEBI LODR Regulations, 2015, and Scrutinizer''s report for 41st Annual General Meeting of the Company. 路 21 Aug 2026
